2,432 Shares in DaVita Inc. (NYSE:DVA) Acquired by Maia Wealth LLC

Maia Wealth LLC bought a new stake in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,432 shares of the company's stock, valued at approximately $364,000.

Several other hedge funds and other institutional investors have also bought and sold shares of DVA. Transcendent Capital Group LLC bought a new position in shares of DaVita in the 3rd quarter worth approximately $25,000. Quarry LP bought a new stake in DaVita during the third quarter worth approximately $60,000. Venturi Wealth Management LLC boosted its position in shares of DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after buying an additional 152 shares during the period. Versant Capital Management Inc boosted its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after buying an additional 169 shares during the period. Finally, Blue Trust Inc. lifted its holdings in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after buying an additional 131 shares during the period. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Trading Down 0.2 %

DaVita stock traded down $0.28 during trading hours on Thursday, reaching $139.72. 456,778 shares of the company's stock traded hands, compared to its average volume of 785,284. The firm's 50 day moving average is $160.19 and its 200-day moving average is $158.12. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The firm has a market capitalization of $11.18 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 1.07 and a beta of 0.99.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

DVA has been the topic of a number of analyst reports. Sanford C. Bernstein set a $184.00 target price on DaVita in a research report on Friday, February 21st. Barclays raised their target price on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.